ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.283,62
0,20%
S&P 500
5.297,10
-0,21%
US Dollar vs BRL
5,1303
0,00%
Bitcoin
65.298,14
0,09%
Brent Oil
83,345
0,17%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Redhill Biopharma Ltd (RDHL)

  7. Redhill Biopharma Ltd (RDHL) Notícias

RDHL

Redhill Biopharma (RDHL)

Redhill Biopharma Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RDHL
DataHoraFonteTítuloCódigoCompanhia
06/05/202408:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:RDHLRedhill Biopharma Ltd
06/05/202408:00PR Newswire (US)RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035NASDAQ:RDHLRedhill Biopharma Ltd
24/04/202408:00PR Newswire (US)RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyNASDAQ:RDHLRedhill Biopharma Ltd
08/04/202410:23PR Newswire (US)RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsNASDAQ:RDHLRedhill Biopharma Ltd
02/04/202408:00PR Newswire (US)RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market PriceNASDAQ:RDHLRedhill Biopharma Ltd
11/03/202408:00PR Newswire (US)RedHill Announces New USPTO Patent Covering Talicia® Through 2034NASDAQ:RDHLRedhill Biopharma Ltd
05/03/202409:00PR Newswire (US)RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsNASDAQ:RDHLRedhill Biopharma Ltd
20/02/202409:00PR Newswire (US)RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationNASDAQ:RDHLRedhill Biopharma Ltd
16/02/202410:54Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:RDHLRedhill Biopharma Ltd
16/02/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RDHLRedhill Biopharma Ltd
05/02/202410:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:RDHLRedhill Biopharma Ltd
02/02/202418:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:RDHLRedhill Biopharma Ltd
26/01/202414:46PR Newswire (US)RedHill Biopharma Announces Closing of $8 Million Registered Direct OfferingNASDAQ:RDHLRedhill Biopharma Ltd
26/01/202411:29Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RDHLRedhill Biopharma Ltd
25/01/202411:05PR Newswire (US)RedHill Biopharma Announces $8 Million Registered Direct OfferingNASDAQ:RDHLRedhill Biopharma Ltd
25/01/202408:00PR Newswire (US)RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042NASDAQ:RDHLRedhill Biopharma Ltd
20/12/202310:45PR Newswire (US)RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against EbolaNASDAQ:RDHLRedhill Biopharma Ltd
12/12/202309:00PR Newswire (US)RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:RDHLRedhill Biopharma Ltd
04/12/202309:00PR Newswire (US)RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 StudyNASDAQ:RDHLRedhill Biopharma Ltd
27/11/202309:00PR Newswire (US)RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034NASDAQ:RDHLRedhill Biopharma Ltd
14/11/202310:00PR Newswire (US)RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital MarketNASDAQ:RDHLRedhill Biopharma Ltd
23/10/202317:06Edgar (US Regulatory)Form F-3/A - Registration statement by foreign private issuers: [Amend]NASDAQ:RDHLRedhill Biopharma Ltd
13/10/202309:13Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:RDHLRedhill Biopharma Ltd
03/10/202308:00PR Newswire (US)RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo StudyNASDAQ:RDHLRedhill Biopharma Ltd
22/09/202317:15PR Newswire (US)RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:RDHLRedhill Biopharma Ltd
18/09/202308:00PR Newswire (US)RedHill Announces FDA sNDA Approval for Talicia®NASDAQ:RDHLRedhill Biopharma Ltd
05/09/202308:00PR Newswire (US)RedHill Announces New USPTO Notice of Patent Allowance for Opaganib and EU Patent Grant for RHB-102 (BEKINDA®)NASDAQ:RDHLRedhill Biopharma Ltd
17/08/202308:00PR Newswire (US)RedHill Biopharma Provides H1/23 Financial Results and Operational HighlightsNASDAQ:RDHLRedhill Biopharma Ltd
01/08/202308:00PR Newswire (US)RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S.NASDAQ:RDHLRedhill Biopharma Ltd
31/07/202308:00PR Newswire (US)RedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDANASDAQ:RDHLRedhill Biopharma Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:RDHL

Seu Histórico Recente

BIT
UC5F0U
Unicredit Bank
BOV
ARZZ3F
AREZZO ON
COIN
BOXTBTC
BIT
HNSC
Hsbc Nasdaq Global Semic...
BIT
F14005
Vontobel Financial Produ...
LSE
0A1O
Zoom Video Communications
USOTC
CRSXF
Corsa Coal (QX)
LSE
ZW95
Citi Fun 27
USOTC
PCIMF
Pacific Imperial Mines (PK)
COIN
BOSTTETH
Bostte
NYSE
CBAH
CBRE Acquisition
UNSW3
HORDETH
HORD Token
EU
F598S
F598S
NYSE
MET-A
MetLife
EU
FR001400OJC7
Engie SA Bond 3875% unti...
GATE
LIKEETH
Only1
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados